Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Pregnancy after lung and heart-lung transplantation: a French multicentre retrospective study of 39 pregnancies.

Bry C, Hubert D, Reynaud-Gaubert M, Dromer C, Mal H, Roux A, Boussaud V, Claustre J, Le Pavec J, Murris-Espin M, Danner-Boucher I.

ERJ Open Res. 2019 Oct 30;5(4). pii: 00254-2018. doi: 10.1183/23120541.00254-2018. eCollection 2019 Oct.

2.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

Burgel PR, Munck A, Durieu I, Chiron R, Mely L, Prevotat A, Murris-Espin M, Porzio M, Abely M, Reix P, Marguet C, Macey J, Sermet-Gaudelus I, Corvol H, Bui S, Lemonnier L, Dehilotte C, Da Silva J, Paillasseur JL, Hubert D; French Cystic Fibrosis Reference Network study group.

Am J Respir Crit Care Med. 2019 Oct 11. doi: 10.1164/rccm.201906-1227OC. [Epub ahead of print]

PMID:
31601120
3.

Vitamins (A&D) and Isoprenoid (Chenodeoxycholic acid) molecules are accompanied by Th1 immunostimulatory response and therapeutic cure in vivo: possible antileishmanial drugs.

Gogulamudi VR, Dubey ML, Kaul D, Hubert DJ, Kandimalla R, Sehgal R.

Sci Rep. 2019 Jun 12;9(1):8531. doi: 10.1038/s41598-019-44630-4.

4.

An automated computed tomography score for the cystic fibrosis lung.

Chassagnon G, Martin C, Burgel PR, Hubert D, Fajac I, Paragios N, Zacharaki EI, Legmann P, Coste J, Revel MP.

Eur Radiol. 2018 Dec;28(12):5111-5120. doi: 10.1007/s00330-018-5516-x. Epub 2018 Jun 4.

PMID:
29869171
5.

A prospective analysis of unplanned patient-initiated contacts in an adult cystic fibrosis centre.

Burnet E, Hubert D, Champreux J, Honoré I, Kanaan R, Panzo R, Burgel PR.

J Cyst Fibros. 2018 Sep;17(5):636-642. doi: 10.1016/j.jcf.2018.04.006. Epub 2018 May 8.

PMID:
29748153
6.

Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial.

Ballmann M, Hubert D, Assael BM, Staab D, Hebestreit A, Naehrlich L, Nickolay T, Prinz N, Holl RW; CFRD Study Group.

Lancet Diabetes Endocrinol. 2018 Feb;6(2):114-121. doi: 10.1016/S2213-8587(17)30400-X. Epub 2017 Dec 5. Erratum in: Lancet Diabetes Endocrinol. 2019 Apr;7(4):e4.

PMID:
29199116
7.

Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases.

Benhabiles H, Gonzalez-Hilarion S, Amand S, Bailly C, Prévotat A, Reix P, Hubert D, Adriaenssens E, Rebuffat S, Tulasne D, Lejeune F.

PLoS One. 2017 Nov 13;12(11):e0187930. doi: 10.1371/journal.pone.0187930. eCollection 2017.

8.

Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2years of treatment with ivacaftor in a real-world setting.

Hubert D, Dehillotte C, Munck A, David V, Baek J, Mely L, Dominique S, Ramel S, Danner Boucher I, Lefeuvre S, Reynaud Q, Colomb-Jung V, Bakouboula P, Lemonnier L.

J Cyst Fibros. 2018 Jan;17(1):89-95. doi: 10.1016/j.jcf.2017.07.001. Epub 2017 Jul 12.

PMID:
28711222
9.

Aqueous extract of Peperomia pellucida (L.) HBK accelerates fracture healing in Wistar rats.

Florence NT, Huguette ST, Hubert DJ, Raceline GK, Desire DD, Pierre K, Theophile D.

BMC Complement Altern Med. 2017 Apr 4;17(1):188. doi: 10.1186/s12906-017-1686-3.

10.

Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease.

Hubert D, Chiron R, Camara B, Grenet D, Prévotat A, Bassinet L, Dominique S, Rault G, Macey J, Honoré I, Kanaan R, Leroy S, Desmazes Dufeu N, Burgel PR.

J Cyst Fibros. 2017 May;16(3):388-391. doi: 10.1016/j.jcf.2017.03.003. Epub 2017 Mar 18.

11.

[New therapeutic developments in cystic fibrosis].

Bui S, Macey J, Fayon M; « nouvelles thérapeutiques de la Société Française pour la Mucoviscidose », Bihouée T, Burgel PR, Colomb V, Corvol H, Durieu I, Hubert D, Marguet C, Mas E, Munck A, Murris-Espin M, Reix P, Sermet-Gaudelus I.

Arch Pediatr. 2016 Dec;23(12S):12S47-12S53. doi: 10.1016/S0929-693X(17)30062-3. Review. French.

PMID:
28231894
12.

Venous thromboembolism capture on electronic systems in obstetrics patients at St Thomas' Hospital.

Ahmad AN, Byrne ML, Imambaccus N, Hubert D, Gateley A, Abdullahi Idle S, Lloyd J.

BMJ Qual Improv Rep. 2016 Oct 19;5(1). pii: u212405.w5122. eCollection 2016.

13.

DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.

Viel M, Hubert D, Burgel PR, Génin E, Honoré I, Martinez B, Gaitch N, Chapron J, Kanaan R, Dusser D, Girodon E, Bienvenu T.

Clin Respir J. 2016 Nov;10(6):777-783. doi: 10.1111/crj.12288. Epub 2015 Apr 15.

PMID:
25763772
14.

Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation.

Sermet-Gaudelus I, Delion M, Durieu I, Jacquot J, Hubert D.

J Cyst Fibros. 2016 Nov;15(6):e67-e69. doi: 10.1016/j.jcf.2016.09.003. Epub 2016 Oct 10.

15.

Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.

Nové-Josserand R, Grard S, Auzou L, Reix P, Murris-Espin M, Brémont F, Mammar B, Mely L, Hubert D, Durieu I, Burgel PR.

Pediatr Pulmonol. 2017 Feb;52(2):190-197. doi: 10.1002/ppul.23612. Epub 2016 Oct 7.

PMID:
27717223
16.

Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy.

Burgel PR, Paugam A, Hubert D, Martin C.

Infect Drug Resist. 2016 Sep 20;9:229-238. eCollection 2016. Review.

17.

Long-term computed tomographic changes in cystic fibrosis patients treated with ivacaftor.

Chassagnon G, Hubert D, Fajac I, Burgel PR, Revel MP; investigators.

Eur Respir J. 2016 Jul;48(1):249-52. doi: 10.1183/13993003.01918-2015. Epub 2016 May 26. No abstract available.

18.

Erratum à l'article « Nouvelles thérapeutiques de la mucoviscidose ciblant le gène ou la protéine CFTR » [Rev. Mal. Respir. (2016). doi: 10.1016/j.rmr.2015.11.010].

Hubert D, Bui S, Marguet C, Colomb-Jung V, Murris-Espin M, Corvol H, Munck A.

Rev Mal Respir. 2016 Jun;33(6):558. doi: 10.1016/j.rmr.2016.02.005. Epub 2016 Apr 23. French. No abstract available.

PMID:
27117927
19.

CFTR and/or pancreatitis susceptibility genes mutations as risk factors of pancreatitis in cystic fibrosis patients?

Gaitch N, Hubert D, Gameiro C, Burgel PR, Houriez F, Martinez B, Honoré I, Chapron J, Kanaan R, Dusser D, Girodon E, Bienvenu T.

Pancreatology. 2016 Jul-Aug;16(4):515-22. doi: 10.1016/j.pan.2016.03.021. Epub 2016 Apr 5.

PMID:
27086061
20.

Maternal and perinatal outcomes of pregnancies in women with cystic fibrosis--A single centre case-control study.

Girault A, Blanc J, Gayet V, Goffinet F, Hubert D.

Respir Med. 2016 Apr;113:22-7. doi: 10.1016/j.rmed.2016.02.010. Epub 2016 Feb 23.

21.

Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy.

Bucher J, Boelle PY, Hubert D, Lebourgeois M, Stremler N, Durieu I, Bremont F, Deneuville E, Delaisi B, Corvol H, Bassinet L, Grenet D, Remus N, Vodoff MV, Boussaud V, Troussier F, Leruez-Ville M, Treluyer JM, Launay O, Sermet-Gaudelus I.

BMC Infect Dis. 2016 Feb 1;16:55. doi: 10.1186/s12879-016-1352-2.

22.

[New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein].

Hubert D, Bui S, Marguet C, Colomb-Jung V, Murris-Espin M, Corvol H, Munck A.

Rev Mal Respir. 2016 Oct;33(8):658-665. doi: 10.1016/j.rmr.2015.11.010. Epub 2016 Jan 21. Review. French.

PMID:
26806675
23.

[CYSTIC FIBROSIS: CARE OF THE LUNG DISEASE].

Hubert D.

Rev Prat. 2015 Oct;65(8):1095-9. French.

PMID:
26749716
24.

Ground-based assessment of the bias and long-term stability of fourteen limb and occultation ozone profile data records.

Hubert D, Lambert JC, Verhoelst T, Granville J, Keppens A, Baray JL, Cortesi U, Degenstein DA, Froidevaux L, Godin-Beekmann S, Hoppel KW, Kyrölä E, Leblanc T, Lichtenberg G, McElroy CT, Murtagh D, Nakane H, Querel R, Russell JM 3rd, Salvador J, Smit HGJ, Stebel K, Steinbrecht W, Strawbridge KB, Stübi R, Swart DPJ, Taha G, Thompson AM, Urban J, van Gijsel JAE, von der Gathen P, Walker KA, Wolfram E, Zawodny JM.

Atmos Meas Tech. 2016;9(6):2497-2534. doi: 10.5194/amtd-8-6661-2015. Epub 2016 Jun 8.

25.

Renin-associated hypertension after bronchial artery embolization in cystic fibrosis.

Coolen N, Gouya H, Kanaan R, Honoré I, Chapron J, Hubert D, Legmann P, Dusser D, Burgel PR.

J Cyst Fibros. 2016 Mar;15(2):213-5. doi: 10.1016/j.jcf.2015.09.003. Epub 2015 Sep 26.

26.

Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!

Martin C, Hamard C, Kanaan R, Boussaud V, Grenet D, Abély M, Hubert D, Munck A, Lemonnier L, Burgel PR.

J Cyst Fibros. 2016 Mar;15(2):204-12. doi: 10.1016/j.jcf.2015.09.002. Epub 2015 Sep 26.

27.

Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.

Coolen N, Morand P, Martin C, Hubert D, Kanaan R, Chapron J, Honoré I, Dusser D, Audureau E, Veziris N, Burgel PR.

J Cyst Fibros. 2015 Sep;14(5):594-9. doi: 10.1016/j.jcf.2015.02.006. Epub 2015 Feb 28.

28.

Complications of peripherally inserted central catheters in adults with cystic fibrosis or bronchiectasis.

Dupont C, Gouya H, Panzo R, Hubert D, Correas JM, Agrario L, Chapron J, Honoré I, Kanaan R, Legmann P, Dusser D, Vignaux O, Burgel PR.

J Vasc Access. 2015 May-Jun;16(3):245-9. doi: 10.5301/jva.5000347. Epub 2015 Feb 4.

PMID:
25656251
29.

Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective study.

Munck A, Kheniche A, Alberti C, Hubert D, Martine RG, Nove-Josserand R, Pin I, Bremont F, Chiron R, Couderc L, Dalphin ML, Darviot E, Delaisi B, Dominique S, Durieu I, Fanton A, Fayon M, Gérardin M, Giniès JL, Giraut C, Grenet D, Guillot M, Huet F, Le Bourgeois M, Murris-Epin M, Ramel S, Sardet A, Sermet-Gaudelus I, Varaigne F, Wanin S, Weiss L, Hurtaud MF.

J Cyst Fibros. 2015 Jan;14(1):97-103. doi: 10.1016/j.jcf.2014.05.015. Epub 2014 Aug 5.

30.

Cystic fibrosis and AA amyloidosis: a survey in the French cystic fibrosis network.

Stankovic Stojanovic K, Hubert D, Leroy S, Dominique S, Grenet D, Colombat M, Clement A, Fayon M, Grateau G.

Amyloid. 2014 Dec;21(4):231-7. doi: 10.3109/13506129.2014.943834. Epub 2014 Jul 23.

PMID:
25054230
31.

Impact of osteopathic treatment on pain in adult patients with cystic fibrosis--a pilot randomized controlled study.

Hubert D, Soubeiran L, Gourmelon F, Grenet D, Serreau R, Perrodeau E, Zegarra-Parodi R, Boutron I.

PLoS One. 2014 Jul 16;9(7):e102465. doi: 10.1371/journal.pone.0102465. eCollection 2014.

32.

Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis.

Launay O, Boelle PY, Krivine A, Grenet D, Boussaud V, Rémus N, Corvol H, Chedevergne F, Hubert D, Sermet-Gaudelus I; Inserm MUCOFLU group.

Vaccine. 2014 Jul 31;32(35):4515-21. doi: 10.1016/j.vaccine.2014.06.010. Epub 2014 Jun 17.

PMID:
24950362
33.

Flagellin concentrations in expectorations from cystic fibrosis patients.

Balloy V, Thévenot G, Bienvenu T, Morand P, Corvol H, Clement A, Ramphal R, Hubert D, Chignard M.

BMC Pulm Med. 2014 Jun 9;14:100. doi: 10.1186/1471-2466-14-100.

34.

Combined effects of climate, resource availability, and plant traits on biomass produced in a Mediterranean rangeland.

Chollet S, Rambal S, Fayolle A, Hubert D, Foulquié D, Garnier E.

Ecology. 2014 Mar;95(3):737-48.

35.

Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.

Ballmann M, Hubert D, Assael BM, Kronfeld K, Honer M, Holl RW; CFRD Study group.

BMC Pediatr. 2014 Mar 11;14:70. doi: 10.1186/1471-2431-14-70.

36.

How to minimize toxic exposure to pyridine during continuous infusion of ceftazidime in patients with cystic fibrosis?

Bourget P, Amin A, Dupont C, Abely M, Desmazes-Dufeu N, Dubus JC, Jouani BL, Merlette C, Nové-Josserand R, Pages J, Panzo R, Vidal F, Voge F, Hubert D.

Antimicrob Agents Chemother. 2014 May;58(5):2849-55. doi: 10.1128/AAC.02637-13. Epub 2014 Mar 10.

37.

p.Arg75Gln, a CFTR variant involved in the risk of CFTR-related disorders?

Martinez B, Heller M, Gaitch N, Hubert D, Burgel PR, Levy P, Girodon E, Bienvenu T.

J Hum Genet. 2014 Apr;59(4):206-10. doi: 10.1038/jhg.2014.2. Epub 2014 Jan 23.

PMID:
24451227
38.

Prognostic value of six minute walk test in cystic fibrosis adults.

Martin C, Chapron J, Hubert D, Kanaan R, Honoré I, Paillasseur JL, Aubourg F, Dinh-Xuan AT, Dusser D, Fajac I, Burgel PR.

Respir Med. 2013 Dec;107(12):1881-7. doi: 10.1016/j.rmed.2013.10.001. Epub 2013 Oct 11.

39.

Rapid emergence of resistance to linezolid and mutator phenotypes in Staphylococcus aureus isolates from an adult cystic fibrosis patient.

Tazi A, Chapron J, Touak G, Longo M, Hubert D, Collobert G, Dusser D, Poyart C, Morand PC.

Antimicrob Agents Chemother. 2013 Oct;57(10):5186-8. doi: 10.1128/AAC.01392-13. Epub 2013 Aug 5.

40.

Mortality associated with chronic external radiation exposure in the French combined cohort of nuclear workers.

Metz-Flamant C, Laurent O, Samson E, Caër-Lorho S, Acker A, Hubert D, Richardson DB, Laurier D.

Occup Environ Med. 2013 Sep;70(9):630-8. doi: 10.1136/oemed-2012-101149. Epub 2013 May 28.

PMID:
23716722
41.

In vivo and in vitro anti-natriuretic activity of twigs fraction from Dorstenia picta: a possible mechanism.

Florence NT, Nicolas M, Raphael C, Hubert DJ, Etienne D, Pierre K, Theophile D, Renaud B.

Pak J Pharm Sci. 2013 May;26(3):537-45.

PMID:
23625427
42.

In vitro leishmanicidal activity of some Cameroonian medicinal plants.

Hubert DJ, Céline N, Michel N, Gogulamudi VR, Florence NT, Johnson BN, Bonaventure NT, Singh IP, Sehgal R.

Exp Parasitol. 2013 Jul;134(3):304-8. doi: 10.1016/j.exppara.2013.03.023. Epub 2013 Apr 4.

PMID:
23562881
43.

CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders.

Thauvin-Robinet C, Munck A, Huet F, de Becdelièvre A, Jimenez C, Lalau G, Gautier E, Rollet J, Flori J, Nové-Josserand R, Soufir JC, Haloun A, Hubert D, Houssin E, Bellis G, Rault G, David A, Janny L, Chiron R, Rives N, Hairion D, Collignon P, Valeri A, Karsenty G, Rossi A, Audrézet MP, Férec C, Leclerc J, Georges Md, Claustres M, Bienvenu T, Gérard B, Boisseau P, Cabet-Bey F, Cheillan D, Feldmann D, Clavel C, Bieth E, Iron A, Simon-Bouy B, Izard V, Steffann J, Viville S, Costa C, Drouineaud V, Fauque P, Binquet C, Bonithon-Kopp C, Morris MA, Faivre L, Goossens M, Roussey M, Girodon E; collaborating working group on p.Arg117His.

J Med Genet. 2013 Apr;50(4):220-7. doi: 10.1136/jmedgenet-2012-101427. Epub 2013 Feb 1.

PMID:
23378603
44.

Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.

Hubert D, Réglier-Poupet H, Sermet-Gaudelus I, Ferroni A, Le Bourgeois M, Burgel PR, Serreau R, Dusser D, Poyart C, Coste J.

J Cyst Fibros. 2013 Sep;12(5):497-503. doi: 10.1016/j.jcf.2012.12.003. Epub 2013 Jan 3.

45.

Specific missense alleles of the arabidopsis jasmonic acid co-receptor COI1 regulate innate immune receptor accumulation and function.

He Y, Chung EH, Hubert DA, Tornero P, Dangl JL.

PLoS Genet. 2012;8(10):e1003018. doi: 10.1371/journal.pgen.1003018. Epub 2012 Oct 18.

46.

Lead optimization of thiazolo[5,4-c]piperidines: 3-cyclobutoxy linker as a key spacer for H(3)R inverse agonists.

Provins L, Denonne F, Célanire S, Christophe B, Defays S, Delaunoy C, Delporte ML, Demaude T, Durieu V, Gillard M, Hubert D, Lamberty Y, Lorent G, Valade A, Vanbellinghen A, Van Houtvin N.

ChemMedChem. 2012 Dec;7(12):2087-92. doi: 10.1002/cmdc.201200406. Epub 2012 Oct 5.

PMID:
23042668
47.

[Vaccination of cystic fibrosis patients].

Iordache L, Gaudelus J, Hubert D, Launay O.

Arch Pediatr. 2012 May;19 Suppl 1:S36-9. doi: 10.1016/S0929-693X(12)71108-9. French.

PMID:
22682490
48.

[The respiratory disease of cystic fibrosis, from infancy to childhood].

Hubert D, Le Bourgeois M.

Arch Pediatr. 2012 May;19 Suppl 1:S17-9. doi: 10.1016/S0929-693X(12)71102-8. French.

PMID:
22682483
49.

Determinants of refusal of A/H1N1 pandemic vaccination in a high risk population: a qualitative approach.

d'Alessandro E, Hubert D, Launay O, Bassinet L, Lortholary O, Jaffre Y, Sermet-Gaudelus I.

PLoS One. 2012;7(4):e34054. doi: 10.1371/journal.pone.0034054. Epub 2012 Apr 10.

50.

High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole.

Burgel PR, Baixench MT, Amsellem M, Audureau E, Chapron J, Kanaan R, Honoré I, Dupouy-Camet J, Dusser D, Klaassen CH, Meis JF, Hubert D, Paugam A.

Antimicrob Agents Chemother. 2012 Feb;56(2):869-74. doi: 10.1128/AAC.05077-11. Epub 2011 Nov 28.

Supplemental Content

Loading ...
Support Center